Tumoral prostate shows different expression pattern of somatostatin receptor 2 (SSTR2) and phosphotyrosine phosphatase SHP-1 (PTPN6) according to tumor progression

Advances in Urology

Volumn , Issue , 2009, Pages

  Zapata, Pedro Darío ^a   Cariaga Martinez, Ariel Ernesto ^a   Lorenzati, María Angelica ^a   Riera, Mario Alejandro ^a   Cubilla, Marisa Angelica ^a   De La Rossa, Andrés ^a   Giorgio, Ernesto Martín ^a   Tiscornia, María Mercedes ^a   Gimenez, Esteban Mariano ^a   Rojas, María Eugenia ^a   Chaneton, Bárbara Julieta ^a   Rodríguez, Dora Isabel ^a  

^a UNIVERSIDAD NACIONAL DE MISIONES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65349099946     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2009/723831     Document Type: Article

References (49)

1. Gurel B., Iwata T., Koh C. M., Yegnasubramanian S., Nelson W. G., De Marzo A. M., Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets Advances in Anatomic Pathology 2008 15 6 319 331
2. Wirén S., Stattin P., Androgens and prostate cancer risk Best Practice and Research Clinical Endocrinology and Metabolism 2008 22 4 601 613
3. Djakiew D., Dysregulated expression of growth factors and their receptors in the development of prostate cancer The Prostate 2000 42 2 150 160 (Pubitemid 30056648)
4. Mayer B. J., Clues to the evolution of complex signaling machinery Proceedings of the National Academy of Sciences of the United States of America 2008 105 28 9453 9454
5. Qian D., Weiss A., T cell antigen receptor signal transduction Current Opinion in Cell Biology 1997 9 2 205 212 (Pubitemid 27135988)
6. Healy J. I., Goodnow C. C., Positive versus negative signaling by lymphocyte antigen receptors Annual Review of Immunology 1998 16 645 670 (Pubitemid 28183380)
7. Siminovitch K. A., Lamhonwah A. M., Somani A. K., Cardiff R., Mills G. B., Involvement of the SHP-1 tyrosine phosphatase in regulating B lymphocyte antigen receptor signaling, proliferation and transformation Current Topics in Microbiology and Immunology 1999 246 291 297 (Pubitemid 29225988)
8. O'Neill L. A. J., When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction Immunity 2008 29 1 12 20
9. Roskoski R. Jr., Src kinase regulation by phosphorylation and dephosphorylation Biochemical and Biophysical Research Communications 2005 331 1 1 14 (Pubitemid 40545134)
10. Pani G., Fischer K. D., Mlinaric-Rascan I., Siminovitch K. A., Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase Journal of Experimental Medicine 1996 184 3 839 852 (Pubitemid 26313542)
11. Roskoski R. Jr., Signaling by Kit protein-tyrosine kinase-the stem cell factor receptor Biochemical and Biophysical Research Communications 2005 337 1 1 13 (Pubitemid 41393751)
12. Brazeau P., Vale W., Burgus R., Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone Science 1973 179 4068 77 79
13. Patel Y. C., Somatostatin and its receptor family Frontiers in Neuroendocrinology 1999 20 3 157 198 (Pubitemid 29362641)
14. Taniyama Y., Suzuki T., Mikami Y., Moriya T., Satomi S., Sasano H., Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study Endocrine Journal 2005 52 5 605 611 (Pubitemid 41609051)
15. Ferone D., van Hagen P. M., Semino C., Somatostatin receptor distribution and function in immune system Digestive and Liver Disease 2004 36 supplement 1 S68 S77 (Pubitemid 41115493)
16. Møller L. N., Stidsen C. E., Hartmann B., Holst J. J., Somatostatin receptors Biochimica et Biophysica Acta 2003 1616 1 1 84 (Pubitemid 37272115)
17. Benali N., Cordelier P., Calise D., Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238 Proceedings of the National Academy of Sciences of the United States of America 2000 97 16 9180 9185 (Pubitemid 30626694)
18. Tagliati F., Zatelli M. C., Bottoni A., Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro Endocrinology 2006 147 7 3530 3538 (Pubitemid 43901144)
19. Lopez F., Estève J.-P., Buscail L., The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling The Journal of Biological Chemistry 1997 272 39 24448 24454 (Pubitemid 27418653)
20. Zapata P. D., Ropero R. M., Valencia A. M., Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1 The Journal of Clinical Endocrinology and Metabolism 2002 87 2 915 926 (Pubitemid 34158272)
21. Alvarez S. E., Seguin L. R., Villarreal R. S., Nahmias C., Ciuffo G. M., Involvement of c-Src tyrosine kinase in SHP-1 phosphatase activation by Ang II AT 2 receptors in rat fetal tissues Journal of Cellular Biochemistry 2008 105 3 703 711
22. Bedecs K., Elbaz N., Sutren M., Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase Biochemical Journal 1997 325 2 449 454 (Pubitemid 27338727)
23. Douziech N., Calvo E., Coulombe Z., Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1 Endocrinology 1999 140 2 765 777 (Pubitemid 29058211)
24. Bousquet C., Delesque N., Lopez F., sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1 The Journal of Biological Chemistry 1998 273 12 7099 7106 (Pubitemid 28160380)
25. Valencia A.-M., Oliva J. L., Bodega G., Identification of a protein-tyrosine phosphatase (SHP1) different from that associated with acid phosphatase in rat prostate FEBS Letters 1997 406 1-2 42 48 (Pubitemid 27156955)
26. Wu C., Sun M., Liu L., Zhou G. W., The function of the protein tyrosine phosphatase SHP-1 in cancer Gene 2003 306 1-2 1 12 (Pubitemid 36351390)
27. Ferjoux G., Bousquet C., Cordelier P., Signal transduction of somatostatin receptors negatively controlling cell proliferation Journal of Physiology 2000 94 3-4 205 210
28. Zapata P. D., Colas B., López-Ruiz P., Phosphotyrosine phosphatase SHP-1, somatostatin and prostate cancer Actas Urológicas Españolas 2004 28 4 269 285
29. Chong Z. Z., Maiese K., The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury Histology and Histopathology 2007 22 11 1251 1267 (Pubitemid 47470319)
30. Tsui H. W., Hasselblatt K., Martin A., Mok S. C.-H., Tsui F. W. L., Molecular mechanisms underlying SHP-1 gene expression European Journal of Biochemistry 2002 269 12 3057 3064 (Pubitemid 34754036)
31. Bruecher-Encke B., Griffin J. D., Neel B. G., Lorenz U., Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation Leukemia 2001 15 9 1424 1432 (Pubitemid 32785312)
32. Barresi V., Alafaci C., Salpietro F., Tuccari G., Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density? Oncology Reports 2008 20 3 485 492
33. Kumar U., Grigorakis S. I., Watt H. L., Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1-5 and correlation with receptor protein expression and tumor pathology Breast Cancer Research and Treatment 2005 92 2 175 186 (Pubitemid 40933583)
34. Zhou T., Xiao X., Xu B., Li H., Zou Y., Overexpression of SSTR2 inhibited the growth of SSTR2-positive tumors via multiple signaling pathways Acta Oncologica 2009 48 3 401 410
35. Oka T., Yoshino T., Hayashi K., Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray The American Journal of Pathology 2001 159 4 1495 1505 (Pubitemid 32947978)
36. Halmos G., Schally A. V., Sun B., Davis R., Bostwick D. G., Plonowski A., High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers The Journal of Clinical Endocrinology and Metabolism 2000 85 7 2564 2571 (Pubitemid 32269216)
37. Sinisi A. A., Bellastella A., Prezioso D., Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer The Journal of Clinical Endocrinology and Metabolism 1997 82 8 2566 2569 (Pubitemid 27337874)
38. Reubi J. C., Waser B., Schaer J. C., Markwalder R., Somatostatin receptors in human prostate and prostate cancer The Journal of Clinical Endocrinology and Metabolism 1995 80 9 2806 2814
39. Kaplan S. A., Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer The Journal of Urology 2003 169 4 1621
40. Tatoud R., Degeorges A., Prévost G., Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog Molecular and Cellular Endocrinology 1995 113 2 195 204
41. Koppan M., Nagy A., Schally A. V., Arencibia J. M., Plonowski A., Halmos G., Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses Cancer Research 1998 58 18 4132 4137 (Pubitemid 28440570)
42. Plonowski A., Schally A. V., Nagy A., Sun B., Szepeshazi K., Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238 Cancer Research 1999 59 8 1947 1953 (Pubitemid 29186170)
43. Ferone D., Resmini E., Boschetti M., Potential indications for somatostatin analogues: immune system and limphoproliferative disorders Journal of Endocrinological Investigation 2005 28 supplement 11 111 117
44. Delibrias C. C., Floettmann J. E., Rowe M., Fearon D. T., Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes Journal of Experimental Medicine 1997 186 9 1575 1583 (Pubitemid 27479817)
45. Wu C., Guan Q., Wang Y., Zhao Z. J., Zhou G. W., SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases Journal of Cellular Biochemistry 2003 90 5 1026 1037 (Pubitemid 37467118)
46. Zhang Q., Lee B., Korecka M., Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I (+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia Leukemia Research 1999 23 4 373 384 (Pubitemid 29166772)
47. Zhang Q., Raghunath P. N., Vonderheid E., ødum N., Wasik M. A., Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter The American Journal of Pathology 2000 157 4 1137 1146
48. Thangaraju M., Sharma K., Liu D., Shen S.-H., Srikant C. B., Interdependent regulation of intracellular acidification and SHP-1 in apoptosis Cancer Research 1999 59 7 1649 1654 (Pubitemid 29160139)
49. Migone T.-S., Cacalano N. A., Taylor N., Yi T., Waldmann T. A., Johnston J. A., Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells Proceedings of the National Academy of Sciences of the United States of America 1998 95 7 3845 3850 (Pubitemid 28173216)